Brief: Netramark Signs Four New Contracts With A Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights
18/11/2025 13:35
NetraMark Holdings Inc AIAI.CD: NETRAMARK SIGNS FOUR NEW CONTRACTS WITH A LEADING GLOBAL PHARMACEUTICAL COMPANY TO ENHANCE CLINICAL TRIAL INSIGHTS Source text: ID:nGNX5zGq51 Further company coverage: AIAI.CD
Recent news on NetraMark Holdings
See all newsBrief: Netramark Announces Uplisting To Toronto Stock Exchange
Brief: Netramark Signs Four New Contracts With A Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights
Brief: Asklepion Pharmaceuticals Signs Contract To Utilize Netramark Technology In Phase III Pediatric Cardiac Study
Brief: NetraMark Holdings Signs Contract With AlgoTx To Enhance Clinical Trial Design For ATX01
Brief: Netramark And Worldwide Clinical Trials Announce Agreement To Transform Clinical Trial Design With Ai-Powered Precision